DHX9-IN-6, identified by its CAS number 2973401-56-6, is a small molecule inhibitor that targets the DEAH-box helicase 9 (DHX9), a protein involved in various cellular processes, including RNA metabolism and gene expression regulation. This compound is characterized by its potential to modulate the activity of DHX9, which may have implications in cancer therapy and other diseases where DHX9 plays a critical role. The molecular structure of DHX9-IN-6 typically includes specific functional groups that enhance its binding affinity to the target protein, contributing to its inhibitory effects. As a research tool, it is often utilized in biochemical assays to study the function of DHX9 and its involvement in cellular pathways. The compound's solubility, stability, and bioavailability are also important characteristics that influence its effectiveness in experimental settings. Overall, DHX9-IN-6 represents a valuable asset in the field of medicinal chemistry and drug discovery, particularly in the context of targeting RNA helicases.

DHX9-IN-6

2973401-56-6: DHX9-IN-6, identified by its CAS number 2973401-56-6, is a small molecule inhibitor that targets the DEAH-box helicase 9 (DHX9), a protein involved in various cellular processes, including RNA metabolism and gene expression regulation. This compound is characterized by its potential to modulate the activity of DHX9, which may have implications in cancer therapy and other diseases where DHX9 plays a critical role. The molecular structure of DHX9-IN-6 typically includes specific functional groups that enhance its binding affinity to the target protein, contributing to its inhibitory effects. As a research tool, it is often utilized in biochemical assays to study the function of DHX9 and its involvement in cellular pathways. The compound's solubility, stability, and bioavailability are also important characteristics that influence its effectiveness in experimental settings. Overall, DHX9-IN-6 represents a valuable asset in the field of medicinal chemistry and drug discovery, particularly in the context of targeting RNA helicases.

DHX9-IN-6 is a highly effective ATP-dependent RNA helicase A (DHX9) inhibitor, used in cancer research.

CAS 2973401-56-6

DHX9-IN-6

DHX9-IN-6

Ref: 54-BUP20200

DHX9-IN-6

Ref: TM-T86202